Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro can cause changes to breath for some people, but the idea that it reliably produces a persistent, foul smell is mostly a misread of what's actually going on. The more accurate picture: a few different mechanisms (some diet-related, some gut-related) can affect breath while you're on tirzepatide, and most are manageable. These are prescription-only medicines requiring clinical assessment before any prescriber will start you on them; a pharmacist or GP is the right person to talk to if you're experiencing something that concerns you. For a fuller look at how breath changes on this treatment tend to play out, the Mounjaro breath overview covers the territory in more detail.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The assumption many people bring to this question is that tirzepatide is somehow releasing a compound that comes out through the breath. That's not what's happening. Tirzepatide works by activating GIP and GLP-1 receptors — it changes how your gut signals fullness, and it slows the rate at which your stomach empties. Those effects are real and clinically meaningful, but they don't directly produce a toxic or malodorous substance that exits through the lungs. What does happen is that the knock-on effects of those changes, particularly how you eat and how your digestion moves food along, can create the conditions for breath to shift. The medicine gets the blame; the culprit is usually somewhere further down the chain.
This is a question our prescribers hear most weeks, and the answer almost always points back to one of two things: a change in what people are eating, or the slower gut motility that tirzepatide produces. Sorting out which one is driving the problem makes the solution much simpler. The detailed breakdown of Mounjaro and bad breath unpacks both pathways.
One of the most noticeable effects of tirzepatide is a significant reduction in appetite. Many people find they naturally move towards eating far fewer carbohydrates, not as a conscious decision, but because they're simply not hungry enough to finish meals that previously felt normal. When carbohydrate intake drops low enough, the body begins drawing on fat stores for energy, producing ketone bodies in the process. One of those ketones, acetone, is exhaled through the lungs. The resulting smell is often described as sweet, fruity or faintly chemical, similar to nail-varnish remover. It's not pleasant, but it is a sign that fat is being metabolised, which is part of the point.
The fix here isn't to eat more carbohydrates for the sake of it, that would undermine the whole process. Staying well hydrated helps significantly, because ketones are partly cleared through urine and adequate fluids support that. Making sure you're getting enough protein and fibre within the calories you do consume also matters. If you'd like structure around this, the eating guidance for people on Mounjaro offers practical, evidence-informed suggestions. For those who want something more detailed, the tirzepatide meal plan covers macronutrient balance specifically.
Tirzepatide slows gastric emptying, this is part of how it prolongs the feeling of fullness after eating. The practical consequence is that food can sit in the stomach for longer than it used to, and that can produce a sour, stale or rotten smell, particularly when burping. Burping is itself a common side effect of GLP-1 receptor agonists, noted on the NHS tirzepatide medicines page. Some people notice the smell is worse after fatty or very rich meals, which take longer to clear the stomach regardless of medication.
Practical adjustments that tend to help: smaller portions (appetite reduction often makes this natural anyway), eating more slowly, avoiding very greasy foods, and not lying down straight after eating. Reflux and indigestion symptoms can accompany the same mechanism, if those are significant, that's worth flagging to your prescriber rather than managing with over-the-counter remedies alone, because there may be interactions or adjustments to consider. There's also a broader look at how tirzepatide reduces appetite and changes eating patterns if the mechanism is of interest.
Most breath changes in the first few weeks of treatment resolve on their own or with the dietary adjustments described above. Ketosis-related breath tends to ease as the body adapts or if carbohydrate intake stabilises. Gut-related smells often improve as gastric emptying patterns settle, which typically happens within the first month or two. Good oral hygiene throughout (brushing, flossing, tongue cleaning, staying hydrated) matters more than it might sound.
However, a few things are worth raising with a clinician. If breath changes are accompanied by severe or persistent abdominal pain, that needs prompt medical attention, the MHRA has flagged pancreatitis as an infrequent but serious risk with GLP-1 medicines, and persistent stomach pain radiating to the back is one of the warning signs to take seriously. If you're losing weight faster than feels healthy or noticing symptoms that concern you beyond breath, speak to your prescriber. The guide to Mounjaro and breath smell changes includes a summary of when symptoms cross from manageable to worth reporting.
If you're considering tirzepatide and want to understand the full picture before starting, the Mounjaro treatment overview covers how it works, who it's licensed for and what a supervised private prescription involves. When you're ready, you can speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered clinician, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.